Search alternatives:
- Subject ("SGLT2 INHIBITORS") »
Loading…
Effects of SGLT-2 inhibitors on adipose tissue distribution in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Wang, Xianghong, Wu, Niujian, Sun, Chuanchuan, Jin, Donghua, Lu, Hongyun
Published in Diabetology and metabolic syndrome (31.05.2023)
Published in Diabetology and metabolic syndrome (31.05.2023)
Get full text
Journal Article
Loading…
Loading…
Efficacy and safety of combination therapy with SGLT2 and DPP4 inhibitors in the treatment of type 2 diabetes: A systematic review and meta-analysis
Cho, Y.K., Kang, Y.M., Lee, S.E., Lee, J., Park, J.-Y., Lee, W.J., Kim, Y.-J., Jung, C.H.
Published in Diabetes & metabolism (01.11.2018)
Published in Diabetes & metabolism (01.11.2018)
Get full text
Journal Article
Loading…
New antidiabetic therapy and HFpEF: light at the end of tunnel?
Tadic, Marijana, Sala, Carla, Saeed, Sahrai, Grassi, Guido, Mancia, Giuseppe, Rottbauer, Wolfang, Cuspidi, Cesare
Published in Heart failure reviews (01.07.2022)
Published in Heart failure reviews (01.07.2022)
Get full text
Journal Article
Loading…
Role of Metformin Monotherapy Vs Metformin Plus Dapagliflozin in New Onset T2DM Among 40 Plus Obese Women in Glycaemic Control
Singh, Amarjeet, Badyal, Ashima, Kotwal, Suman, Tandon, Vishal R
Published in JK science : journal of medical education and research (01.10.2024)
Get full text
Published in JK science : journal of medical education and research (01.10.2024)
Journal Article
Loading…
Elevated liver enzymes and comorbidities in type 2 diabetes: A multicentre analysis of 51 645 patients from the Diabetes Prospective Follow‐up (DPV) database
Meyhöfer, Svenja, Eckert, Alexander J., Hummel, Michael, Laimer, Markus, Roden, Michael, Kress, Stephan, Seufert, Jochen, Meyhöfer, Sebastian M., Holl, Reinhard W.
Published in Diabetes, obesity & metabolism (01.04.2022)
Published in Diabetes, obesity & metabolism (01.04.2022)
Get full text
Journal Article
Loading…
Supplementation with Highly Standardized Cranberry Extract Phytosome Achieved the Modulation of Urinary Tract Infection Episodes in Diabetic Postmenopausal Women Taking SGLT-2 Inhibitors: A RCT Study
Rondanelli, Mariangela, Mansueto, Francesca, Gasparri, Clara, Solerte, Sebastiano Bruno, Misiano, Paola, Perna, Simone
Published in Nutrients (02.07.2024)
Published in Nutrients (02.07.2024)
Get full text
Journal Article
Loading…
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database
Antonazzo, Ippazio Cosimo, Rozza, Davide, Cortesi, Paolo Angelo, Fornari, Carla, Zanzottera Ferrari, Elena, Paris, Claire, Eteve-Pitsaer, Caroline, Gnesi, Marco, Mele, Silvia, D’Amelio, Marco, Maurizi, Anna Rita, Palladino, Pasquale, Mantovani, Lorenzo Giovanni, Mazzaglia, Giampiero
Published in Acta diabetologica (01.03.2025)
Published in Acta diabetologica (01.03.2025)
Get full text
Journal Article
Loading…
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
Sundström, Johan, Kristófi, Robin, Östlund, Ollie, Bennet, Louise, Eliasson, Björn, Jansson, Stefan, Leksell, Janeth, Almby, Kristina, Lundqvist, Martin, Eriksson, Jan W.
Published in Journal of diabetes and its complications (01.10.2021)
Published in Journal of diabetes and its complications (01.10.2021)
Get full text
Journal Article
Loading…
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, Paul A., Bozkurt, Biykem, Aguilar, David, Allen, Larry A., Byun, Joni J., Colvin, Monica M., Deswal, Anita, Drazner, Mark H., Dunlay, Shannon M., Evers, Linda R., Fang, James C., Fedson, Savitri E., Fonarow, Gregg C., Hayek, Salim S., Hernandez, Adrian F., Khazanie, Prateeti, Kittleson, Michelle M., Lee, Christopher S., Link, Mark S., Milano, Carmelo A., Nnacheta, Lorraine C., Sandhu, Alexander T., Stevenson, Lynne Warner, Vardeny, Orly, Vest, Amanda R., Yancy, Clyde W.
Published in Journal of the American College of Cardiology (03.05.2022)
Published in Journal of the American College of Cardiology (03.05.2022)
Get full text
Journal Article
Loading…
Loading…
Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice
Montero-Pérez-Barquero, Manuel, Escobar-Cervantes, Carlos, Arévalo-Lorido, José Carlos, Conde-Martel, Alicia, Salamanca-Bautista, Prado, Manzano-Espinosa, Luis, Formiga, Francesc, Díez-Manglano, Jesús, Cepeda, José María, González-Franco, Alvaro, Casado-Cerrada, Jesús
Published in Future cardiology (01.05.2023)
Published in Future cardiology (01.05.2023)
Get full text
Journal Article
Loading…
Benefits of dapagliflozin in the whole spectrum of heart failure in clinical practice: the RICA registry
Montero-Pérez-Barquero, Manuel, Escobar-Cervantes, Carlos, Dávila-Ramos, Melitón Francisco, Suárez-Pedreira, Iván, Pérez-Silvestre, José, Ceresuela-Eito, Luis Miguel, Muela-Molinero, Alberto, Quesada-Simón, María Angustias, Formiga, Francesc, González-Franco, Alvaro, Casado-Cerrada, Jesús
Published in Future cardiology (01.05.2023)
Published in Future cardiology (01.05.2023)
Get full text
Journal Article
Loading…
Influence of Hepatic Impairment on the Pharmacokinetics and Safety Profile of Dapagliflozin: An Open-Label, Parallel-Group, Single-Dose Study
Kasichayanula, Sreeneeranj, Liu, Xiaoni, Zhang, Weijiang, Pfister, Marc, LaCreta, Frank P., Boulton, David W.
Published in Clinical therapeutics (01.11.2011)
Published in Clinical therapeutics (01.11.2011)
Get full text
Journal Article
Loading…
Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study
Lee, Paul Chi Ho, Gu, Yunjuan, Yeung, Man Yi, Fong, Carol Ho Yi, Woo, Yu Cho, Chow, Wing Sun, Tan, Kathryn, Lam, Karen Siu Ling
Published in Diabetes therapy (01.02.2018)
Published in Diabetes therapy (01.02.2018)
Get full text
Journal Article
Loading…
Place of sodium-glucose cotransporter-2 inhibitors in East Asian subjects with type 2 diabetes mellitus: Insights into the management of Asian phenotype
Lim, Lee Ling, Tan, Alexander Tong Boon, Moses, Kevin, Rajadhyaksha, Viraj, Chan, Siew Pheng
Published in Journal of diabetes and its complications (01.02.2017)
Published in Journal of diabetes and its complications (01.02.2017)
Get full text
Journal Article
Loading…
Clinical Benefit of Switching from Low-Dose to High-Dose Empagliflozin in Patients with Type 2 Diabetes
Matsumura, Takeshi, Makabe, Tomoko, Ueda, Seiko, Fujimoto, Yuki, Sadahiro, Kayo, Tsuruyama, Shiori, Ookubo, Yuma, Kondo, Tatsuya, Araki, Eiichi
Published in Diabetes therapy (01.09.2022)
Published in Diabetes therapy (01.09.2022)
Get full text
Journal Article
Loading…
Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
Hundertmark, Moritz J., Agbaje, Olorunsola F., Coleman, Ruth, George, Jyothis T., Grempler, Rolf, Holman, Rury R., Lamlum, Hanan, Lee, Jisoo, Milton, Joanne E., Niessen, Heiko G., Rider, Oliver, Rodgers, Christopher T., Valkovič, Ladislav, Wicks, Eleanor, Mahmod, Masliza, Neubauer, Stefan
Published in ESC Heart Failure (01.08.2021)
Published in ESC Heart Failure (01.08.2021)
Get full text
Journal Article
Loading…
Effect of Add-On Therapy of Sodium-Glucose Cotransporter 2 Inhibitors and Dipeptidyl Peptidase 4 Inhibitors on Adipokines in Type 2 Diabetes Mellitus
Shaheer, Abid, Kumar, Ashok, Menon, Palat, Jallo, Mahir, Basha, Shaikh
Published in Journal of clinical medicine research (01.06.2021)
Published in Journal of clinical medicine research (01.06.2021)
Get full text
Journal Article
Loading…